Antepartum Hemorrhage

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Antepartum Hemorrhage trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07025954

Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta

Current clinical practice guidelines recommend planned cesarean delivery(CD) at 34-37 weeks of gestation in pregnant women with placenta previa and accreta. Pre…

China600 participantsStarted 2025-07-12

Treatment: Cesarean delivery

RecruitingNot Applicable

NCT05802251

Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study

The aim of this study is to evaluate the effectiveness of ultrasonographic parameters (cervical length, placental thickness and distance placental edge from int…

Egypt68 participantsStarted 2022-06-01

Treatment: Ultrasonographic parameters

All recent trials (15 shown)

UnknownNot Applicable

NCT05645848

The Rate and Predictors of Vaginal Bleeding Among Women With Placenta Previa

Placenta previa is usually diagnosed when the placenta implanted in the lower uterine segment, thus partially or totally overlying the internal os . It occurs w…

Location not specified250 participantsStarted 2022-12

Treatment: Ultrasonography

CompletedNot Applicable

NCT04725929

Vaginal Progesterone Against a Second Attack of Antepartum Haemorrhage in Placenta Previa Women

Placenta praevia is associated with an increased risk of preterm delivery (PTD) especially if associated with bleeding and uterine contractions . In this study…

Egypt160 participantsStarted 2021-01-01

Antepartum Hemorrhage

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta

Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study

All recent trials (15 shown)

The Rate and Predictors of Vaginal Bleeding Among Women With Placenta Previa

Vaginal Progesterone Against a Second Attack of Antepartum Haemorrhage in Placenta Previa Women

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta

Sonographic Parameters and Risk of Antepartum Hemorrhage in Asymptomatic Women With Placenta Previa: A Cohort Study

All recent trials (15 shown)

The Rate and Predictors of Vaginal Bleeding Among Women With Placenta Previa

Vaginal Progesterone Against a Second Attack of Antepartum Haemorrhage in Placenta Previa Women

Effects of Peri Partum Integrated Nursing Care Versus Routine Care in Placenta Previa : A Randomized Controlled Trail

Strengthening Maternal Neonatal and Child Health Services in a Rural District of Pakistan

Tranexamic Acid in Pregnancies With Vaginal Bleeding

Antenatal Tranexamic Acid in Women With Symptomatic Placenta Previa

Reliability of Simple Sonographic Findings Acquired With Hand-held Apparatuses to Inform Obstetric Diagnosis

Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa

17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta Previa

Progesterone and Second Trimester Bleeding

Cervical Length in Cases of Placenta Previa

Doppler Imaging and Morbidly Adherent Placenta

Plethysmography Variability Index Monitoring for Parturients With Antepartum Hemorrhage